Article
Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide
Zhang, H., Schneider, S. E., Bray, B., Friedrich, P., Tvermoes, N., Mader, C., Whight, S., Niemi, T., Silinski, P., Picking, T., Warren, M., & Wring, S. (2007). Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide. Organic Process Research and Development, 12(1), 101 - 110.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Recent Publications
Article
The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article
Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article